We are live on ! Find out more
Viking Global Investors

Viking Global Investors Portfolio holdings

AUM $35.7B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
+27.12%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$23.1B
AUM Growth
+$3.93B
Cap. Flow
-$364M
Cap. Flow %
-1.58%
Top 10 Hldgs %
44.28%
Holding
88
New
24
Increased
15
Reduced
29
Closed
16

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$980M
2
AMZN icon
Amazon
AMZN
+$645M
3
JD icon
JD.com
JD
+$536M
4
BSX icon
Boston Scientific
BSX
+$481M
5
LOW icon
Lowe's Companies
LOW
+$429M

Sector Composition

Rank Sector Weight
1 Healthcare 32.37%
2 Consumer Discretionary 19.72%
3 Technology 19.48%
4 Financials 14.6%
5 Communication Services 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WDAY icon
26
Workday
WDAY
$45B
$279M 1.21%
1,490,882
-971,096
-39% -$157M
CB icon
27
Chubb
CB
$134B
$279M 1.21%
2,202,033
+1,283,492
+140% +$149M
MCO icon
28
Moody's
MCO
$83B
$269M 1.16%
+977,348
New +$248M
PH icon
29
Parker-Hannifin
PH
$135B
$264M 1.14%
+1,442,793
New +$233M
PLAN
30
DELISTED
Anaplan, Inc.
PLAN
$260M 1.13%
5,746,829
+5,630,107
+4,824% +$236M
GH icon
31
Guardant Health
GH
$22.3B
$249M 1.08%
3,068,173
-730,277
-19% -$58.8M
ADI icon
32
Analog Devices
ADI
$188B
$240M 1.04%
+1,959,943
New +$215M
LOW icon
33
Lowe's Companies
LOW
$124B
$231M 1%
1,710,360
-3,759,784
-69% -$429M
SHW icon
34
Sherwin-Williams
SHW
$88.2B
$230M 0.99%
+1,193,505
New +$215M
DRI icon
35
Darden Restaurants
DRI
$24.8B
$227M 0.98%
+2,991,636
New +$212M
ZNTL icon
36
Zentalis Pharmaceuticals
ZNTL
$299M
$213M 0.92%
+4,443,284
New +$170M
EXAS
37
DELISTED
Exact Sciences
EXAS
$190M 0.82%
2,182,534
-245,036
-10% -$19.6M
SE icon
38
Sea Limited
SE
$80.5B
$185M 0.8%
1,727,380
+403,516
+30% +$29.2M
MOH icon
39
Molina Healthcare
MOH
$10.2B
$180M 0.78%
1,013,668
-351,584
-26% -$59.9M
MU icon
40
Micron Technology
MU
$957B
$175M 0.76%
3,392,745
-3,318,924
-49% -$156M
ALL icon
41
Allstate
ALL
$67.6B
$172M 0.74%
+1,769,570
New +$174M
LIN icon
42
Linde
LIN
$226B
$170M 0.74%
+803,694
New +$155M
EHC icon
43
Encompass Health
EHC
$12.4B
$166M 0.72%
3,365,758
+1,547,946
+85% +$83.5M
NFLX icon
44
Netflix
NFLX
$311B
$162M 0.7%
3,565,490
-23,026,980
-87% -$980M
DHR icon
45
Danaher
DHR
$146B
$160M 0.69%
+1,019,632
New +$146M
BABA icon
46
Alibaba
BABA
$307B
$150M 0.65%
+695,536
New +$145M
ALGN icon
47
Align Technology
ALGN
$12.3B
$148M 0.64%
+539,343
New +$121M
BPMC
48
DELISTED
Blueprint Medicines
BPMC
$127M 0.55%
1,629,716
+29,249
+2% +$1.98M
RPRX icon
49
Royalty Pharma
RPRX
$26.1B
$122M 0.53%
+2,514,985
New +$124M
CTLT
50
DELISTED
CATALENT, INC.
CTLT
$109M 0.47%
1,493,703
-444,225
-23% -$30.2M

Similar funds

Viking Global Investors's Q2 2020 Portfolio in Review

As of Q2 2020, Viking Global Investors held 88 positions worth $23.1B, up 20% from $19.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Viking Global Investors's Q2 2020 filing shows 24 new, 15 increased, 29 reduced and 16 closed positions. Its largest new stake was Thermo Fisher Scientific: 1,734,144 shares worth $628M. The largest sale was Netflix, an estimated $980M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Viking Global Investors's largest Q2 2020 buy was Thermo Fisher Scientific: 1,734,144 shares worth $628M.
  • Viking Global Investors added most to American Express in Q2 2020, an estimated $609M increase.
  • Viking Global Investors's biggest Q2 2020 reduction was Netflix, cutting an estimated $980M.
  • Viking Global Investors fully exited Elevance Health in Q2 2020, selling an estimated $411M.
  • Viking Global Investors's ten largest holdings make up 44% of its $23.1B portfolio in Q2 2020.
  • Viking Global Investors opened 24 new positions and closed 16 in Q2 2020.
  • Viking Global Investors's portfolio value rose 20% quarter-over-quarter to $23.1B.

Based on Viking Global Investors's 13F filing for Q2 2020, filed 7 Aug 2020.